DRUG MARKETING Off-label marketing: free speech or illegal promotion?

被引：1
|
作者：
Silverman, Ed [1 ]
机构：
[1] Pharmalot, Millburn, NJ USA
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2013年 / 346卷
关键词：
D O I：
10.1136/bmj.f320
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Free Speech, Drug Marketing, and Off-Label Use
    Vivian, Jesse C.
    [J]. US PHARMACIST, 2011, 36 (12) : 46 - 48
  • [2] Off-label marketing: free speech or illegal promotion? (vol 346, f320, 2013)
    Silverman, Ed
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [3] Off-label drug promotion and the ephemeral line between marketing and education
    Krause, Joan H.
    [J]. JOURNAL OF LAW AND THE BIOSCIENCES, 2015, 2 (03): : 705 - 711
  • [4] Off-Label Use vs Off-Label Marketing Part 2: Off-Label Marketing- Consequences for Patients, Clinicians, and Researchers
    Van Norman, Gail A.
    [J]. JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (03): : 359 - 370
  • [5] Whistleblowers Take On Off-Label Marketing
    Noller, Lisa M.
    Waltz, Judith A.
    [J]. GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2010, 30 (21): : 11 - 12
  • [6] Off-Label Marketing and the First Amendment
    Boumil, Marcia M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (02): : 103 - 105
  • [7] Off-label drug promotion
    不详
    [J]. ONCOLOGY-NEW YORK, 1999, 13 (12): : 1616 - 1616
  • [8] Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing
    Kesselheim, Aaron S.
    Woloshin, Steven
    Lu, Zhigang
    Tessema, Frazer A.
    Ross, Kathryn M.
    Schwartz, Lisa M.
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (05) : 707 - 709
  • [9] Off-Label Drug Use and Promotion
    Gianutsos, Gerald
    [J]. US PHARMACIST, 2014, 39 (10) : 55 - 64
  • [10] Another use of oxycontin: The case for enhancing liability for off-label drug marketing
    Ford, MA
    [J]. BOSTON UNIVERSITY LAW REVIEW, 2003, 83 (02) : 429 - 464
12345